Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

E-ISSN： 1876-1038|10|2|128-134

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.10, Iss.2, 2015-01, pp. : 128-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

By Wyndaele Jean-Jacques

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 485-494

Future Medicine

Access to resources Recommend Favorite

An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity

Urologia Internationalis, Vol. 89, Iss. 3, 2012-07 ,pp. : 259-269

Karger

Access to resources Recommend Favorite

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment

BJU INTERNATIONAL, Vol. 116, Iss. 6, 2015-12 ,pp. : 853-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 379-385

Karger

Access to resources Recommend Favorite